Finally, in one small randomized controlled trial, suppression of the cough reflex by the P2X3 inhibitor gefapixant in patients with IPF did not significantly improve IPF-related cough [131]. This evidence concerns the gene P2RX3 and idiopathic pulmonary fibrosis.